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Abstract
Background: Intraoperative device closure of perimembranous ventricular septal defect(VSD) through a lower
mini-sternotomy is safe, less invasive, and has excellent surgical and cosmetic outcomes. Our study is to evaluate
the feasibility of closing VSD under guidance of trans-epicardial echocardiography.
Methods: We reviewed the clinical course of 41 patients referred to our institution for minimally invasive closure of
perimembranous VSD. The trans-epicardial echocardiography(TEE) was used to monitor the whole procedure to
guide the positioning of device and evaluate the operative effect instantly after operation.
Result: The procedure was successfully done in 38 patients(92.6 %) with mean age of 1.2 ± 1.5 years(range 0.5-6.
1 years),mean weight of 10.78 ± 6.87 kg(range 5.2 ~ 26 kg) and VSD size of 5.1 ± 1.13 mm(range 5 ~ 10 mm). Three
cases failed, including two cases whose guide-wires could not pass through VSDs and one case whose occluder
could not repair VSD well. Three patients had tiny residual shunts because of the shifting of occluders. There were
no major complications such as arrhythmia, valve regurgitation and the failure of occluder during follow-up(Mean
2.3 ± 1.2 years). TEE provided superior imaging of shapes and surrounding structures of the VSDs, and guide-wires
passing through VSDs.
Conclusions: Intraoperative device closure of perimembranous VSD through a lower mini-sternotomy without
cardiopulmonary bypass appears to be a safe and effective procedure. The use of trans-epicardial echocardiography
provides useful information for intraoperative device closure of VSD.
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Background
Perimembranous ventricular septal defect(VSD) is one
of the most common congenital cardiac malformations.
Closure of VSD is routinely performed with cardiopul-
monary bypass,or interventional transcatheter occlusion
is performed for some selected patients [1, 2]. Traditional
open heart surgery is safe with excellent outcomes, but
this method with cardiopulmonary bypass is associated
with postoperative complications [3–5]. The percutaneous
device closure of perimembranous VSD is minimally inva-
sive, but can be challenging because of low patient weight
or poor vascular access, as well as multiple exposures to
medical radiation [6, 7].
In recent years, intraoperative device closure of perimem-
branous VSD through a lower mini-sternotomy without
cardiopulmonary has been introduced and applied clinically
as an alternative treatment option [8–10]. Previous reports
have demonstrated the safety and efficacy of this minimally
invasive technique [9–11]. The transoesophageal or trans-
thoracic echocardiography plays an important role in the
process of selection of patients and closure of VSD [12].
However, little is known about the effectiveness of
trans-epicardial echocardiography closure of perimem-
branous VSD during this procedure. Therefore, in the
study, we reported the safety and efficacy of intraopera-
tive device closure of perimenbranous VSD and evalu-




Between May 2011 through June 2014, 41 patients with
isolated perimembranous VSDs receiving the closure of
VSD with an Amplatzer device (Shanghai Memory Alloy
Company,Shanghai,China) using a lower mini-sternotomy
approach under the guidance of trans-epicardial echocar-
diography at our hospital, were retrospectively reviewed.
In our study, there were 16 females and 25 males, and the
ages ranged from 0.5 to 6 years, the diameter of the VSDs
ranged from 3 mm to 8.5 mm. Patients’ characteristics are
listed in Table 1.
Patients were enrolled in this study for the following
indications: (1) a hemodynamically left-to-right shunt;
(2) the diameter of the Perimembranous VSD at the
right-sided exit of at least 2 mm; (3) the subaortic
rim(the distance from the defect to the aortic valve) of
more than 1 mm. The following patients were excluded:
(1) more than mild degree of aortic valve prolapse; (2)
severe pulmonary hypertension; (3) newborn or young
infants with a large VSD; (4) coexisting cardiac anomal-
ies that need to be corrected at the same procedure.
Routine examinations included an electrocardiogra-
m(ECG), a chest X-ray, and at least twice transthoracic
echocardiography. Blood tests were done to exclude
contraindications to antiplatelet therapy.
The informed consent about to participate in the study
was obtained from the patient or guardian who was fully
informed of the available treatment options. This tech-
nique was approved by the ethics committee of our
hospital.
Trans-epicardial echocardiography
Transthoracic echocardiography studies were performed
to evaluate the position、size、shape and the surround-
ing rimes (especially the subaortic rim) of VSDs before
the operations. After general anesthesia and a single-
lumen tracheal intubation, patients were placed in a
supine position. A continuous trans-epicardial echocar-
diography was used to monitor deployment of the
devices. All patients were screened in the five-chamber
view and left ventricular long-axis view to measure the
diameter of the exit and entry (the left ventricular open-
ing) of the defect. After deployment of the devices, the
devices position and the integrity of the adjacent valve
and the presence of residual shunt were assessed by
trans-epicardial echocardiography repeatedly.
Device and implantation technique
The technique of intraoperative device closure of peri-
membranous ventricular septal defect without cardiopul-
monary bypass has been described in recent reports with
some modifications [9, 11, 13]. There are three types of
devices(Shanghai Shape Memory Alloy Co.Ltd, China)
used in this study. An concentric occlude device with
short-edged or wide-edged was about 2-4 mm in size
larger than the connecting waist, while the superior part
of left disc of an eccentric occlude device is as same as
the diameter of VSD so as to prevent impingement of the
aortic valve, and the inferior part with a metallic mark to
indicate its location is 5.0 mm larger than the connecting
Table 1 Successfully ICOD patient characteristic (N = 38)
Variable Values
age (years) 1.2 ± 1.5 (range 0.5 ~ 6)
Gender (F/M) 16/25
Weight (kg) 10.78 ± 6.87 (range 5 ~ 26)
Max-diameter of VSD (mm) 5.2 ± 1.13 (range 3 ~ 8)
Device size (mm) 6.8 ± 1.6 (range 5–10)
Hospital stay (days) 9 ± 3 (range, 6–12)
In-hospial complication
Residual shunt (n) 3 (<2 mm)
Follow-up complication
Residual shunt (n) 1 (<2 mm)
Follow-up time (years) 2.3 ± 1.2 (range, 0.5–3)
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waist. The right ventricular disc in the eccentric side is
2 mm larger than the waist. The delivery system includes
a flexible guide-wire, double-lumen plastic delivery sheath
and a loading sheath. Patients were placed in a surgical
position under general anesthesia. A 3- to 4- cm lower
partial median sternotomy and a pericardiotomy were per-
formed [9]. The surface of right ventricular was exposed
and heparinization was performed (1.0 mg/kg). Surgeon
then determined the puncture site by slightly palpating
the right ventricular free wall and locating the area of
maximal thrill. A pledgetted 4-0 polypropylene mattress
was placed at this location, and the free wall was punc-
tured within the suture with a 20-G needle. A flexible
hyperechogenic guide-wire was inserted and moved
toward the exit of VSD under the guidance of trans-
epicardial echocardiography, and then advanced through
the defect, the needle was removed. A double lumen deliv-
ery sheath was introduced over the guide-wire under the
guidance of trans-epicardial echocardiography, establish-
ing the delivery pathway. During this process, the right
ventricular orifice and guide-wire should be clearly
continuously viewed through trans-epicardial echocardi-
ography and imaging plane.
The occlude device was delivered along the sheath.
Holding the delivery sheath and then the left ventricular
disc was deployed by pushing the cable forward. After
deployment of left ventricular disc, the delivery sheath
and cable were slowly and simultaneously withdrawn
until the left disc was snugly against the ventricular
septum wall, and the waist as well as the right ventricu-
lar disc was released. After the occlude device was fully
deployed, surgeon should test its stability by using a to-
and-fro motion maneuver repeatedly before the delivery
system was removed. In order to ensure that the eccentric
occluder was released in an appropriate position, the oc-
clude device was adjusted until the eccentric side of the
disc was opposite to the aortic valve and faced towards
the heart apex after the marker of eccentric side were vi-
sualized by trans-epicardial echocardiography (Fig. 1).
Because the perimembranous VSD is closed to the aor-
tic valve, valve regurgitation or right ventricular outflow
tract obstruction should be avoided. First, the occluder
could be easily retracted and redeployed in case of
inappropriate released position of the occlude device. Sec-
ond, it was crucial for the operator to be very cautious
during releasing the occlude device.
Trans-epicardial echocardiography study was then per-
formed to assess positioning of the device, residual
shunt, and device malposition as well as any obstruction
or regurgitation of the valve induced by device [9, 12].
The degree of residual shunt was assessed by measuring
width of the color jet [12]. Trans-epicardial echocardiog-
raphy was kept for 15 min to observe the position of
device before the sheath was withdrawn. The purse-
string was snugly tied and heparin was neutralized after
the sheath was then withdrawn. After a drainage tube
Fig. 1 The steps of periventricular device closure of perimembranous VSD. (a) A trans-epicardial echocardiography view after a small stenotomy. (b)
A surgeon handles the guide-wire under the guidance of trans-epicardial echocardiography. (c) Blood launching from the delivery sheath after it
passed through the defect in to the left ventricle. (d) A right disc was deployed at first step. (e) A device was completely deployed and the
delivery sheath will be kept for 5 min. (f) A device was successfully deployed without any complications
Sun et al. Journal of Cardiothoracic Surgery  (2016) 11:87 Page 3 of 6
was placed in the pericardium, the mini-thoracotomy
was closed.
Follow-up
Prophylactic antibiotics were administrated before the
procedure and last for 24 h for prophylaxis of bacterial
endocarditis. After operation, low dose oral aspirin (3 ~
4 mg/kg/day) was given to the patients and was contin-
ued for at least six months.
The follow-up protocol included an ECG and TTE that
were scheduled at discharge, 3, 6, 12 months after the pro-
cedure. The position and stability of the device, residual
shunt and procedure-induced valve complication were
carefully checked during the follow-up examination.
Data analysis
Datas are expressed as median or mean ± SD and range.
Results
Intraoperative and Early postoperative period
A total of 38 patients(92.8 %) underwent intraoperative
device closure of perimembranous VSD, and the proced-
ure was converted to conventional open repair under car-
diopulmonary bypass in the remaining 3 patients(7.2 %).
The sizes of the exits of perimenbranous VSDs ranged
from 3.0 mm to 8.5 mm(5.45 ± 1.27 mm), and the sizes of
occluders ranged from 5 mm to 10 mm. In the successful
VSD cases, the concentric occlude devices with wide-
edged were implanted in 27 patients(71.1 %) and the
eccentric occlude devices were implanted in the remaining
patients. All the patients did not require transfusion of
blood products.
New trivial or mild residual shunt was detected in 3
patients(8 %) by intraoperative trans-epicardial echocar-
diography. No worsening tricuspid valve regurgitation
was observed in those with existing tricuspid regurgita-
tion before surgery, and no more than mild degree of
regurgitation was found in this study. No obvious aortic
valve regurgitation was detected during the procedure.
No incomplete bundle branch block or complete atrio-
ventricular block was detected during the procedure or
before discharge.
All successful patients were extubated within 2 h after
the procedure, and were discharged in 5 days.
Conversion to open repair
Three patients had unsuccessful procedures, which were
all converted to conventional open repair with cardio-
pulmonary bypass. The guide-wire failed to cross the
VSD in 2 patients after we moved guide-wire repeatedly
and tried different puncture areas. During the surgery,
membranous aneurysms and the size of VSD small than
3 mm were found in 1 patient, and the entry on the LV
side and the exit of membranous aneurysm on the RV
side were not in the same axis in another patient. A 5-
mm occlude device was successfully implanted in a 3-
mm membranous aneurysm VSD under the guidance of
trans-epicardial echocardiography, but it fell off in 1 day
after operation. During open surgery, weak and friable
wall of the membranous aneurysm VSD with more than
10-mm size on the LV side was found.
Follow-up results
Follow-up period of all successful patients ranged from
0.5 to 3 years(mean2.3 ± 1.2 years). The short and mid-
term follow-up results were available by electrocardiog-
raphy and trans-epicardial echocardiography, 38 patients
for 1 month、3 months、and 6 months,27 patients for
1 year, and 19 patients for 2 years and 12 patients for
more than 3 years. Symptoms were much improved or
totally resolved in all symptomatic patients. Small shunts
were found in 3 patients immediately after operation.
After 6 months follow-up for these 3 patients, shunts
disappeared in 2 patients and remaining shunt decreased
in another patient. No occlude device dislocation,
thrombosis, complete heart block, new aortic regurgita-
tion and other major complications were found during
the follow-up period.
Discussion
Intraoperative device closure of perimembranous VSDs
without cardiopulmonary bypass was first reported by
Amin and cleagus [5], and has become an accepted mo-
dality of treatment in many cardiac centers [6, 9, 13].
This approach has many important advantages com-
pared with conventional surgery, though surgical closure
has been considered as a standard technique with opti-
mal long-term result for permembranous VSD for a long
time. This technique has many advantages, including no
potential complications of CPB, surgical trauma, no need
for blood transfusion, shorter time in ICU, smaller inci-
sion, less pain for patients and faster recovery and
cosmetic result. In recent years, percutaneous closure
perimembranous VSD as an accepted alternative treat-
ment option to cardiac surgery [14, 15]. Details of this
technique and its encouraging mild-term outcomes have
been extensively described in several studies [16]. How-
ever, this method is associated with many disadvantages
including the limitation of vascular access, the complex-
ity of technique, perforation of the heart, tricuspid valve
damage. Meanwhile, residual shunt, the malposition and
failure of device are common [17].
Additionally, this technique needs more advanced and
expensive equipment [18]. Compared with the percutan-
eous procedure, the advantages of periventricular tech-
nique seem to be obvious. First, there is no vascular access
injury from sheath insertion or guide-wire, and this tech-
nique is not constrained by patients age and weight
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compared with transcatheter intervention. Second, the de-
vice can be easily controlled and adjusted during the pro-
cedure, because periventricular technique has excellent
manipulability of a short and straight sheath and guide-
wire, the reliability of testing the stability of device for a
to-and-fro maneuver. With the trans-apeicardial echocar-
diography imaging, this technique is easier and safer. In
case of the occlude device dropping off or inappropriate
selection of cases for device closure, full sternotomy can
be more quickly performed to close the VSD under CPB,
because the procedure is performed by the same surgeon
in the operating room. Third, there is no exposure to radi-
ation especially for children, and more advanced equip-
ment is not needed in periventricular technique.
The key point of periventricular VSD closure is that
sheath and guide-wire should pass through the VSD under
echocardiography imaging [13, 19]. Transoesophageal
echocardiography, which was done immediately before,
during and after deployment of the occlude device, has
been considered as a standard technique for this proced-
ure [12]. Once the device is released, a repeat transoeso-
phageal echocardiography is performed to assess the
position of device, the presence of residual shunt and aor-
tic valve regurgitation. Trans-epicardial echocardiography
can provide useful information for intraoperative device
closure of perimembranous VSD. However, little is known
about the effectiveness of periventricular close of peri-
membranous VSD using trans-epicardial echocardiog-
raphy. The site, size, and rims of the defect, the suitability
for device, and guiding the guide-wire and sheath to pass
through the VSD can be detected by trans-epicardial
echocardiography with clear imaging during the proced-
ure. The reference position, which is also the region of
interest, was based on the whole structure of the peri-
membranous VSD. We also found that trans-epicardial
echocardiography could provide more clear view of
vessels when surgeons are trying to pass through the
perimembranous VSD with the guide-wire and sheath.
Compared with transoesophageal echocardiography, the
advantages of trans-epical echocardiography are no need
of a transoesophageal probe and no operation trauma.
Several factors contribute to the success of the in-
traoperative device closure of perimembranous VSD
[13, 19, 20]. First, the size of perimembranous VSD is
small (<3 mm) and the jet of VSD directs toward the
tricuspid valve, therefore, it will be very difficult for
sheath to pass through VSD with a smaller diameter
of defect, which may result in the failure of implantation.
Second, in our experience, the occlude device closure may
fail if the sensitive finger could not feel the murmur on
the surface of right ventricular free wall after a small lower
sternotomy. Third, the perimembranous aneurysm VSD
usually has soft rim. According to our experience, it is rec-
ommended that in such case with VSD of a soft rim, the
size of the occlude device should be 4 or 5 mm larger than
the maximum diameter of VSD. And in order to avoid the
failure of device and the presence of residual shunt, opera-
tors should adjust device repeatedly until it is released.
In one perimembranous aneurysm VSD patient, no re-
sidual shunt or device malposition was observed after
procedure, however, the device failed in 1 day after oper-
ation because of the weak and friable wall of the mem-
branous aneurysm and malposition of occluder.
In our study, only one occlude device failed in 1 day
after operation, and no complete AVB or left bundle
branch block occurred, aortic valve insufficiency or device
embolization was observed in this group. As mentioned
earlier, compared with the transcatheter intervention, only
a shorter delivery pathway is required and no sheath or
guide-wire passes through the atrial-ventricular valve in
this technique. The eccentric side of the occlude device
can be easily manipulated by the operators, and the device
can be adjusted to face the heart apex to avoid the risk of
aortic valve regurgitation. Therefore, the incidence of
complications related to the catheter-placed occlude de-
vices was very low in this group. Because the VSDs are
small in diameter and the jet flow may face towards the
sheath, and there are many other structures(tricuspid
valve and its tendons) around the perimembranous VSDs,
it will be difficult for beginners to pass the sheath
through the VSDs. In our experience, a real-time
trans-epicardial echocardiography monitoring by expe-
rienced cardiologists and the handling the guide-wire
and sheath flexibly by surgeons can solve this prob-
lem. The VSD repair under CPB could be finished by
cardiac surgeons themselves, and after 10 to 20 oper-
ations, the entire procedure was simplified.
Limitations
All the findings of this study should be interpreted with
caution considering the following limitations. First, al-
though the techniques of the periventricular closure of
perimembranous VSD under trans-epicardial echocardi-
ography guiding seem to be safe in the mid-term follow-
up, more experience and long-time follow-up results are
necessary to assess the actual effectiveness and safety of
this technique as an alternative to conventional surgery
and transcatheter intervention. Second, this study is not
a prospective randomized study, therefore, despite of the
excellent results, we just draw the conclusion with past
experiences and results of this technique.
Conclusions
In conclusion, as far as we know, this is the first pub-
lished report of mid-term follow-up outcome of intraop-
erative device closure of perimembranous VSD under
trans-epicardial echocardiography. Intraoperative device
closure of perimembranous VSD is minimally invasive,
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safe, cosmetic and feasible for many patients, and as well
as for infants. A small lower sternotomy and trans-
epicardial echocardiography make it unlimited to the
age and weight of patients.
Abbreviations
AR, Aortic regurgitation; AVB, Atrioventricular block; CPB, Cardiopulmonary






This surgery was done by YS, PZ, PZ and YG. YS and PZ drafted the
manuscript. SZ revised the manuscript and all authors read and approved
the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 12 March 2016 Accepted: 17 May 2016
References
1. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of
ventricular septal defects. Circulation. 1988;78:361–8.
2. Murzi B, Bonanomi GL, Giusti S, Luisi VS, Bernabei M, Carminati M, Vanini V.
Surgical closure of muscular ventricular septal defects using double
umbrella devices (intraoperative VSD device closure). Eur J Cardiothorac
Surg. 1997;12:450–4. discussion 454-455.
3. Yang XC, Liu DB. Minimally invasive perventricular device closure of
ventricular septal defect: a comparative study in 80 patients. Chin Med Sci J.
2014;29:98–102.
4. Omelchenko AY, Zhuang Z, Schreiber C, Gorbatykh YN, Arkhipov AN,
Malakhova OY, Zaitsev GS. Surgical off-pump closure of perimembranous
ventricular septal defects. Asian Cardiovasc Thorac Ann. 2014;22:31–5.
5. Amin Z, Gu X, Berry JM, Titus JL, Gidding SS, Rocchini AP. Perventricular
[correction of Periventricular] closure of ventricular septal defects without
cardiopulmonary bypass. Ann Thorac Surg. 1999;68:149–53. discussion 153-144.
6. Omelchenko A, Gorbatykh Y, Voitov A, Zaitsev G, Bogachev-Prokophiev A,
Karaskov A. Perventricular device closure of ventricular septal defects: results
in patients less than 1 year of agedagger. Interact Cardiovasc Thorac Surg.
2016;22:53–6.
7. Zeng XJ, Sun SQ, Chen XF, Ma XJ, Luo YH, Lim YP, Tao L. Device closure of
perimembranous ventricular septal defects with a minimally invasive
technique in 12 patients. Ann Thorac Surg. 2008;85:192–4.
8. Bacha EA, Cao QL, Starr JP, Waight D, Ebeid MR, Hijazi ZM. Perventricular
device closure of muscular ventricular septal defects on the beating heart:
technique and results. J Thorac Cardiovasc Surg. 2003;126:1718–23.
9. Xing Q, Pan S, An Q, Zhang Z, Li J, Li F, Wu Q, Zhuang Z. Minimally invasive
perventricular device closure of perimembranous ventricular septal defect
without cardiopulmonary bypass: multicenter experience and mid-term
follow-up. J Thorac Cardiovasc Surg. 2010;139:1409–15.
10. Xing Q, Wu Q, Shi L, Xing Y, Yu G. Minimally invasive transthoracic device
closure of isolated ventricular septal defects without cardiopulmonary bypass:
long-term follow-up results. J Thorac Cardiovasc Surg. 2015;149:257–64.
11. Zhang S, Zhu D, An Q, Tang H, Li D, Lin K. Minimally invasive perventricular
device closure of doubly committed sub-arterial ventricular septal defects:
single center long-term follow-up results. J Cardiothorac Surg. 2015;10:119.
12. Yang Y, Gao L, Xu X, Zhao T, Yang J, Gao Z, Yin N, Xiong L, Xie L, Huang C,
et al. Echocardiographic assessment and guidance in minimally invasive
surgical device closure of perimembranous ventricular septal defects. Heart
Surg Forum. 2014;17:E206–211.
13. Hongxin L, Zhang N, Wenbin G, Zhang WL, Wang ZJ, Liang F, Zou CW.
Peratrial device closure of perimembranous ventricular septal defects
through a right parasternal approach. Ann Thorac Surg. 2014;98:668–74.
14. Schreiber C, Vogt M, Kuhn A, Horer J, Samprec J, Zhongyun Z, Fengwei Z,
Lange R. Periventricular closure of a perimembranous VSD: treatment
option in selected patients. Thorac Cardiovasc Surg. 2012;60:78–80.
15. Varma C, Benson LN, Silversides C, Yip J, Warr MR, Webb G, Siu SC, McLaughlin
PR. Outcomes and alternative techniques for device closure of the large
secundum atrial septal defect. Catheter Cardiovasc Interv. 2004;61:131–9.
16. El Said HG, Bratincsak A, Gordon BM, Moore JW. Closure of
perimembranous ventricular septal defects with aneurysmal tissue using the
Amplazter Duct Occluder I: lessons learned and medium term follow up.
Catheter Cardiovasc Interv. 2012;80:895–903.
17. Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, Giamberti A,
Pome G, Bossone E, Frigiola A. Early and late complications associated with
transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol.
2002;39:1061–5.
18. Vida VL, Barnoya J, O'Connell M, Leon-Wyss J, Larrazabal LA, Castaneda AR.
Surgical versus percutaneous occlusion of ostium secundum atrial septal
defects: results and cost-effective considerations in a low-income country.
J Am Coll Cardiol. 2006;47:326–31.
19. Hongxin L, Lijun S, Wang ZJ, Zi J, Zhang WL, Zhang HZ, Wenbin G, Zou CW.
Intraoperative device closure of large secundum atrial septal defects; a safe
alternative to transcatheter closure. Eur J Cardiothorac Surg. 2008;33:1055–60.
20. Zhu D, Lin K, Tang ML, Feng Y, An Q. Midterm results of hybrid
perventricular closure of doubly committed subarterial ventricular septal
defects in pediatric patients. J Card Surg. 2014;29:546–53.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Sun et al. Journal of Cardiothoracic Surgery  (2016) 11:87 Page 6 of 6
